CSIMarket
 


Cumberland Pharmaceuticals Inc  (CPIX)
Other Ticker:  
 

Cumberland Pharmaceuticals Inc's Long Term Debt to Equity

CPIX's quarterly Long Term Debt to Equity and Long Term Debt, Equity growth


In Spite of the long-term debt repayement of -1.08%, in IV Quarter 2023 ,Long Term Debt to Equity deteriorated to 0.44 is above the company's typical Long Term Debt to Equity.

Within Major Pharmaceutical Preparations industry in the forth quarter 2023, 26 other companies have achieved lower Long Term Debt to Equity than Cumberland Pharmaceuticals Inc in the IV Quarter 2023. While Long Term Debt to Equity total ranking has improved so far in the forth quarter 2023 to 799, from total ranking in the third quarter 2023 at 807 .

Explain Long Term Debt to Equity Ratio?
How much Long Term Debt CPIX´s has?
What is the structure of CPIX´s Equity?


CPIX Long Term Debt to Equity (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity Change -18.66 % -7.37 % -6.04 % -11.63 % -15.56 %
Y / Y Long Term Debt Change -21.09 % -26.99 % -30.8 % -19.64 % 8 %
Long Term Debt to Equity MRQ 0.44 0.36 0.36 0.45 0.45
CPIX's Total Ranking # 799 # 807 # 1074 # 968 # 1097
Seq. Equity Change -17.94 % -3.21 % 2.19 % 0.21 % -6.54 %
Seq. Long Term Debt Change -1.08 % -1.71 % -18.19 % -0.79 % -8.47 %



Long Term Debt to Equity forth quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 27
Healthcare Sector # 77
Overall Market # 799


Long Term Debt to Equity Statistics
High Average Low
0.49 0.23 0.02
(Mar 31 2022)   (Jun 30 2015)




Financial Statements
Cumberland Pharmaceuticals Inc's Equity $ 29 Millions Visit CPIX's Balance sheet
Cumberland Pharmaceuticals Inc's Long Term Debt $ 13 Millions Visit CPIX's Balance sheet
Source of CPIX's Sales Visit CPIX's Sales by Geography


Cumulative Cumberland Pharmaceuticals Inc's Long Term Debt to Equity

CPIX's Long Term Debt to Equity for the trailling 12 Months

CPIX Long Term Debt to Equity

(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity TTM Growth -18.66 % -7.37 % -6.04 % -11.63 % -15.56 %
Y / Y Long Term Debt TTM Growth -21.09 % -26.99 % -30.8 % -19.64 % 8 %
Long Term Debt to Equity TTM 0.4 0.4 0.43 0.46 0.47
Total Ranking TTM # 39 # 51 # 92 # 1466 # 114
Seq. Equity TTM Growth -17.94 % -3.21 % 2.19 % 0.21 % -6.54 %
Seq. Long Term Debt TTM Growth -1.08 % -1.71 % -18.19 % -0.79 % -8.47 %


On the trailing twelve months basis Due to long-term debt repayement of -1.08% Cumberland Pharmaceuticals Inc has not changed Long Term Debt to Equity in the 12 months ending in IV Quarter 2023 to 0.4, above the Cumberland Pharmaceuticals Inc's average Long Term Debt to Equity.
Long Term Debt to Equity is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry only one has achieved lower Long Term Debt to Equity. While Long Term Debt to Equity total ranking has improved so far to 39, from total ranking in previous 12 month period at 51.

Explain Long Term Debt to Equity Ratio?
How much Long Term Debt CPIX´s has?
What is the structure of CPIX´s Equity?

TTM Long Term Debt to Equity Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 2
Healthcare Sector # 8
Within the Market # 39


trailing twelve months Long Term Debt to Equity Statistics
High Average Low
0.47 0.33 0.11
(Dec 31 2022)   (Dec 31 2017)




Companies with similar Long Term Debt to Equity in the quarter ending Dec 31 2023, within Major Pharmaceutical Preparations Industry Long Term Debt to EquityDec 31 2023 MRQ Long Term DebtDec 31 2023 MRQ Equity
Lexicon Pharmaceuticals Inc   1.07 $ 99.508  Millions$ 93.110  Millions
Eyenovia inc   1.00 $ 8.957  Millions$ 8.999  Millions
Elanco Animal Health Inc  0.92 $ 5,736.000  Millions$ 6,223.000  Millions
Merck and Co Inc   0.89 $ 33,683.000  Millions$ 37,635.000  Millions
Ocular Therapeutix Inc   0.82 $ 74.925  Millions$ 91.131  Millions
Viatris Inc   0.79 $ 16,188.100  Millions$ 20,467.400  Millions
Cryoport inc   0.78 $ 379.888  Millions$ 489.023  Millions
Perrigo Company Plc  0.76 $ 3,632.800  Millions$ 4,767.900  Millions
Prestige Consumer Healthcare Inc   0.75 $ 1,199.340  Millions$ 1,600.577  Millions
Vaxxinity Inc   0.71 $ 9.527  Millions$ 13.409  Millions
Verastem inc   0.70 $ 40.086  Millions$ 57.374  Millions
Pfizer Inc  0.69 $ 61,538.000  Millions$ 89,288.000  Millions
Emergent Biosolutions Inc   0.69 $ 446.500  Millions$ 649.300  Millions
Ani Pharmaceuticals Inc  0.66 $ 284.819  Millions$ 432.749  Millions
Mersana Therapeutics Inc   0.63 $ 23.148  Millions$ 36.904  Millions
Royalty Pharma Plc  0.61 $ 6,135.285  Millions$ 10,084.289  Millions
Aytu Biopharma Inc   0.46 $ 14.978  Millions$ 32.853  Millions
Cumberland Pharmaceuticals Inc  0.44 $ 12.784  Millions$ 29.260  Millions
Soligenix inc   0.40 $ 1.011  Millions$ 2.522  Millions
Harmony Biosciences Holdings inc   0.38 $ 178.566  Millions$ 466.992  Millions
Johnson and Johnson  0.38 $ 25,881.000  Millions$ 68,774.000  Millions
Ardelyx Inc   0.30 $ 49.822  Millions$ 166.816  Millions
Werewolf Therapeutics Inc   0.29 $ 32.656  Millions$ 111.374  Millions
Madrigal Pharmaceuticals Inc   0.28 $ 115.480  Millions$ 405.333  Millions
Assertio Holdings inc   0.28 $ 38.514  Millions$ 138.003  Millions
Verona Pharma Plc  0.19 $ 48.374  Millions$ 249.283  Millions
Capricor Therapeutics inc   0.15 $ 3.376  Millions$ 22.601  Millions
Clene Inc   0.14 $ 1.894  Millions$ 13.390  Millions
Kamada Ltd   0.14 $ 34.379  Millions$ 244.021  Millions
Compass Pathways Plc  0.13 $ 28.757  Millions$ 225.744  Millions

Date modified: 2024-03-13T18:26:48+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com